---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-069070"
form_type: "8-K"
ticker: "BDTX"
cik: "0001701541"
company_name: "Black Diamond Therapeutics, Inc."
filed_at: "2024-06-06T23:59:59+00:00"
generated_at: "2026-06-01T05:56:18.867117+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Black Diamond Therapeutics shareholders approve officer liability limitation and elect directors

## Summary
- Shareholders approved Amendment to limit officer liability as permitted by Delaware law.
- Prakash Raman and Mark A. Velleca elected as Class I directors to serve until 2027.
- PricewaterhouseCoopers LLP ratified as independent auditor for FY2024.
- Certificate of Amendment filed and effective June 6, 2024.

## SEC filing metadata
- accession: 0001104659-24-069070
- form_type: 8-K
- ticker: BDTX
- cik: 0001701541
- company_name: Black Diamond Therapeutics, Inc.
- filed_at: 2024-06-06T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.03, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1701541/000110465924069070/0001104659-24-069070-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1701541/000110465924069070/tm2416636d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-069070
- JSON: https://secwatch.observer/filing/0001104659-24-069070.json
- Plain text: https://secwatch.observer/filing/0001104659-24-069070.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.